Nektar Therapeutics (NKTR)
60.98
+0.06 (0.10%)
Upcoming Events
Latest Headlines
Form 4 NEKTAR THERAPEUTICS For: Jun 16 Filed by: ROBIN HOWARD W
June 18, 2026 7:08 PM - SEC Filing
Form 4 NEKTAR THERAPEUTICS For: Jun 15 Filed by: Zalevsky Jonathan
June 17, 2026 7:13 PM - SEC Filing
Form 144 NEKTAR THERAPEUTICS Filed by: ROBIN HOWARD W
June 17, 2026 11:06 AM - SEC Filing
Form 144 NEKTAR THERAPEUTICS Filed by: ROBIN HOWARD W
June 16, 2026 11:07 AM - SEC Filing
Form 144 NEKTAR THERAPEUTICS Filed by: Zalevsky Jonathan
June 15, 2026 4:57 PM - SEC Filing
Form 8-K NEKTAR THERAPEUTICS For: Jun 05
June 5, 2026 4:31 PM - SEC Filing
Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 3, 2026 4:15 PM - PR NewsWire
Nektar Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference in New York
May 27, 2026 6:16 PM - PR NewsWire
Form 3 NEKTAR THERAPEUTICS For: May 15 Filed by: Rubinstein Linda M
May 26, 2026 6:20 PM - SEC Filing
Form 4 NEKTAR THERAPEUTICS For: May 19 Filed by: Zalevsky Jonathan
May 21, 2026 6:27 PM - SEC Filing
Form 4 NEKTAR THERAPEUTICS For: May 19 Filed by: ROBIN HOWARD W
May 21, 2026 6:26 PM - SEC Filing
Form 144 NEKTAR THERAPEUTICS Filed by: Zalevsky Jonathan
May 19, 2026 3:28 PM - SEC Filing
Form 144 NEKTAR THERAPEUTICS Filed by: ROBIN HOWARD W
May 19, 2026 3:25 PM - SEC Filing
Form SCHEDULE 13G/A NEKTAR THERAPEUTICS Filed by: BIOTECHNOLOGY VALUE FUND L P
May 15, 2026 4:19 PM - SEC Filing
Form 424B5 NEKTAR THERAPEUTICS
May 8, 2026 5:23 PM - SEC Filing
Form 8-K NEKTAR THERAPEUTICS For: May 08
May 8, 2026 5:11 PM - SEC Filing
Nektar Therapeutics (NKTR ) PT Raised to $192 at Piper Sandler
May 8, 2026 7:58 AM - StreetInsider
Form 10-Q NEKTAR THERAPEUTICS For: Mar 31
May 8, 2026 6:03 AM - SEC Filing
Nektar Therapeutics (NKTR) Misses Q1 EPS by 182c
May 7, 2026 4:38 PM - StreetInsider
Form 8-K NEKTAR THERAPEUTICS For: May 07
May 7, 2026 4:33 PM - SEC Filing
Nektar Therapeutics Reports First Quarter 2026 Financial Results
May 7, 2026 4:15 PM - PR NewsWire
Form SCHEDULE 13G/A NEKTAR THERAPEUTICS Filed by: FMR LLC
May 6, 2026 11:31 AM - SEC Filing
Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 1, 2026 4:40 PM - PR NewsWire
Nektar Therapeutics (NKTR) call put ratio 1 call to 3.8 puts with a focus on May puts
April 29, 2026 2:54 PM - StreetInsider
Nektar to Announce Financial Results for the First Quarter on Thursday, May 7, 2026, After Close of U.S.-Based Financial Markets
April 28, 2026 6:00 PM - PR NewsWire
Form ARS NEKTAR THERAPEUTICS For: Dec 31
April 24, 2026 4:19 PM - SEC Filing
Form DEFA14A NEKTAR THERAPEUTICS
April 24, 2026 4:18 PM - SEC Filing
Form DEF 14A NEKTAR THERAPEUTICS For: Jun 04
April 24, 2026 4:16 PM - SEC Filing
Nektar Therapeutics completes $373.8 million stock offering
April 23, 2026 4:15 PM - StreetInsider
Nektar Therapeutics Announces Closing of $373.8 Million Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares
April 23, 2026 4:15 PM - PR NewsWire
Form 8-K NEKTAR THERAPEUTICS For: Apr 21
April 23, 2026 6:06 AM - SEC Filing
Form 424B5 NEKTAR THERAPEUTICS
April 23, 2026 6:05 AM - SEC Filing
Nektar Therapeutics (NKTR) PT Raised to $150 at Jefferies
April 22, 2026 12:21 PM - StreetInsider
Nektar prices upsized $325 million public offering at $92 per share
April 21, 2026 9:30 PM - StreetInsider
Nektar Therapeutics Announces Pricing of Upsized $325 Million Public Offering
April 21, 2026 9:30 PM - PR NewsWire
Nektar Therapeutics (NKTR) PT Raised to $151 at Citi
April 21, 2026 3:48 AM - StreetInsider
Form 424B5 NEKTAR THERAPEUTICS
April 20, 2026 5:01 PM - SEC Filing
Form 8-K NEKTAR THERAPEUTICS For: Apr 20
April 20, 2026 4:59 PM - SEC Filing
Nektar Therapeutics launches $250 million public offering
April 20, 2026 4:01 PM - StreetInsider
Nektar Therapeutics Announces Proposed Public Offering
April 20, 2026 4:01 PM - PR NewsWire
Nektar Therapeutics (NKTR) PT Raised to $95 at Wedbush
April 20, 2026 10:57 AM - StreetInsider
Nektar Therapeutics (NKTR) PT Raised to $185 at H.C. Wainwright
April 20, 2026 10:35 AM - StreetInsider
Nektar Therapeutics (NKTR) PT Raised to $178 at BTIG
April 20, 2026 10:21 AM - StreetInsider
Jefferies stays Buy on Nektar Therapeutics (NKTR) after Rezpeg data hits upside estimates, sees 10-30% stock move into Ph3
April 20, 2026 9:48 AM - StreetInsider
Oppenheimer Reiterates Outperform Rating on Nektar Therapeutics (NKTR)
April 20, 2026 8:23 AM - StreetInsider
Form 8-K NEKTAR THERAPEUTICS For: Apr 20
April 20, 2026 8:02 AM - SEC Filing
Nektar Therapeutics reports positive 52-week data for alopecia areata drug trial
April 20, 2026 7:30 AM - StreetInsider
Nektar Therapeutics (NKTR) Halted, News Pending
April 20, 2026 7:30 AM - StreetInsider
52-Week Topline Results from 16-Week Blinded Treatment Extension of REZOLVE-AA Demonstrate Deepening of Responses in Severe-to-Very-Severe Alopecia Areata with Rezpegaldesleukin
April 20, 2026 7:30 AM - PR NewsWire
Nektar Therapeutics to discuss alopecia areata trial results
April 19, 2026 12:00 PM - StreetInsider
Nektar to Hold Conference Call to Discuss 52-Week Topline Results from the 16-Week Extension Treatment Period for its REZOLVE-AA Phase 2b Study of Rezpegaldesleukin in Alopecia Areata on April 20, 202
April 19, 2026 12:00 PM - PR NewsWire
Form SCHEDULE 13G NEKTAR THERAPEUTICS Filed by: Two Seas Capital LP
April 17, 2026 9:01 AM - SEC Filing
Bernstein on US Pharma and Biotech: Who might buy whom?
April 13, 2026 5:52 AM - StreetInsider
Citi Adds Nektar Therapeutics (NKTR) to 30-Day Upside Catalyst Watch List
April 7, 2026 8:36 AM - StreetInsider
Oppenheimer on Nektar Therapeutics (NKTR): 'meaningful opportunities for biologics in AA'
April 1, 2026 9:57 AM - StreetInsider
Nektar presents rezpegaldesleukin data at dermatology meeting
March 28, 2026 12:36 PM - StreetInsider
Data from Phase 2b REZOLVE-AD and REZOLVE-AA Studies of Rezpegaldesleukin Presented at 2026 American Academy of Dermatology Annual Meeting
March 28, 2026 12:36 PM - PR NewsWire
Form SCHEDULE 13G/A NEKTAR THERAPEUTICS Filed by: VANGUARD GROUP INC
March 27, 2026 10:49 AM - SEC Filing
Wedbush Starts Nektar Therapeutics (NKTR) at Neutral
March 24, 2026 6:53 AM - StreetInsider
Full Article List
